CYP2C19 Genotyping to Guide Antiplatelet Therapy After Percutaneous Coronary Interventions One Size Rarely Fits All

Moliterno David J.; Smyth Susan S.; Abdel-Latif Ahmed

首页> 外文期刊>JAMA: the Journal of the American Medical Association >CYP2C19 Genotyping to Guide Antiplatelet Therapy After Percutaneous Coronary Interventions One Size Rarely Fits All

【24h】

CYP2C19 Genotyping to Guide Antiplatelet Therapy After Percutaneous Coronary Interventions One Size Rarely Fits All

机译：CYP2C19基因分型以经皮冠状动脉干预后引导抗血小板治疗一个尺寸很少适合所有

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《JAMA: the Journal of the American Medical Association》 |2020年第8期|共3页
作者
Moliterno David J.; Smyth Susan S.; Abdel-Latif Ahmed;
展开▼
作者单位

Univ Kentucky Div Cardiovasc Med Gill Heart Inst Lexington KY USA;

Univ Kentucky Div Cardiovasc Med Gill Heart Inst Lexington KY USA;

Univ Kentucky Div Cardiovasc Med Gill Heart Inst Lexington KY USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医药、卫生;
关键词

相似文献

外文文献
中文文献
专利

1. CYP2C19 Genotyping to Guide Antiplatelet Therapy After Percutaneous Coronary Interventions One Size Rarely Fits All [J] . Moliterno David J., Smyth Susan S., Abdel-Latif Ahmed JAMA: the Journal of the American Medical Association . 2020,第8期

机译：CYP2C19基因分型以经皮冠状动脉干预后引导抗血小板治疗一个尺寸很少适合所有
2. CYP2C19 GENOTYPE-GUIDED ESCALATION AND DE-ESCALATION SWITCHING OF ANTIPLATELET THERAPY AFTER PERCUTANEOUS CORONARY INTERVENTION IN A REAL-WORLD SETTING. [J] . Martin J., Williams A. K., Klein M. D., Clinical Pharmacology and Therapeutics . 2019,第Suppla1期

机译：CYP2C19基因型引导升级和抗血小板治疗在真实世界环境中经皮冠状动脉介入后的抗血小板治疗的脱升升级切换。
3. CYP2C19 GENOTYPE-GUIDED ESCALATION AND DE-ESCALATION SWITCHING OF ANTIPLATELET THERAPY AFTER PERCUTANEOUS CORONARY INTERVENTION IN A REAL-WORLD SETTING. [J] . Martin J., Williams A. K., Klein M. D., Clinical Pharmacology and Therapeutics . 2019,第Suppla1期

机译：CYP2C19基因型引导升级和抗血小板治疗在真实世界环境中经皮冠状动脉介入后的抗血小板治疗的脱升升级切换。
4. Review of Image-Guided Percutaneous Coronary Interventions [C] . Aseel Alatoom, Jumana Farhat, Salam Dhou Advances in Science and Engineering Technology International Conferences . 2019

机译：影像引导的经皮冠状动脉介入治疗的综述
5. The Association between Unfractionated Heparin and Bivalirudin Used during Percutaneous Coronary Intervention for Stable Angina and Acute Coronary Syndromes and the In-Hospital and Mortality Outcomes Observed across All Body Mass Index Groups [D] . Chen, Christine. 2021

机译：在所有体重指数群体中观察到稳定冠状动脉干预期间使用经皮冠状动脉介入和急性冠状动脉综合征的冠状动脉介入和医院和死亡率结果之间的联合肝素和Bivalirudin之间的关联
6. Impact of Implementing CYP2C19 Genotype-Guided Antiplatelet Therapy on P2Y12 Inhibitor Selection and Clinical Outcomes in Acute Coronary Syndrome Patients After Percutaneous Coronary Intervention: A Real-World Study in China [O] . Yi Zhang, Xiu-Jin Shi, Wen-Xing Peng, 2020

机译：经皮冠状动脉干预后实施CYP2C19基因型引导抗血小板治疗抗血小板治疗对急性冠状动脉综合征患者P2Y12抑制剂选择及临床结果的影响：中国的真实研究
7. CYP2C19 Genotype-Guided Antiplatelet Therapy and 30-Day Outcomes After Percutaneous Coronary Intervention [O] . Alexis K. Williams, Melissa D. Klein, Jesse Martin, 2019

机译：CYP2C19基因型引导抗血小板治疗和经皮冠状动脉干预后的30天后

CYP2C19 Genotyping to Guide Antiplatelet Therapy After Percutaneous Coronary Interventions One Size Rarely Fits All

著录项

引文网络

相似文献

相关主题

期刊订阅